This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Small-Caps Surge Up to 1,640% in a Year

5. Global Axcess (GAXC), an owner of 4,500 ATMs and DVD kiosks in the U.S., returned 514% over the past year. Global Axcess hasn't yet "broken the buck" and is currently trading over-the-counter at around 89 cents a share, with a market value of $19 million. During the past three years, Global Axcess has increased profit 31% annually, on average. Considering that growth rate, the stock appears undervalued at a price-to-earnings ratio of 11.

4. Culp (CFI), a maker of mattress and upholstery fabrics, ascended 563% during the past year. Culp endured a difficult fiscal 2009, posting losses in its second and third quarters, but then mounted a successful turnaround. It swung to a fiscal second-quarter profit of $2.9 million, or 22 cents a share, from a loss of $41 million, or $3.23, a year earlier. The company's operating margin widened from 3.7% to 7.6%.

3. High-tech-equipment maker Veeco Instruments (VECO) climbed 578% in the past 12 months. Veeco designs equipment used by the data storage, semiconductor and wireless industries. It suffered losses in the first half of 2009, but resumed profitability in the third and fourth quarters. The company possesses a liquid balance sheet, with $284 million of cash and $101 million of debt.

2. Biotech darling Dendreon (DNDN) soared 726% during the past year as investors placed bets on prostate cancer drug Provenge. Dendreon is consistently unprofitable, but Provenge is in the final stage of Food and Drug Administration approval, with a notification deadline of May 1. If the drug meets criteria, Dendreon plans to commercialize independently in the U.S. It's considering overseas partnerships.

2 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs